Drovelis: an oral contraceptive with drospirenone and estetrol-Reference-Cited by-同舟云学术

Drovelis: an oral contraceptive with drospirenone and estetrol

Published:2023-04 Issue:4 Volume:34 Page:31-32
ISSN:0959-6682
Container-title:Prescriber
language:en
Short-container-title:Prescriber

Author:

Chaplin Steve¹

Affiliation:

1. Steve Chaplin is a medical writer specialising in therapeutics

Abstract

Drovelis is a new combined oral contraceptive (COC) containing drospirenone and estetrol. This article discusses its dosing requirements, clinical trial efficacy and adverse effects.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology (nursing)

Reference6 articles.

1. Medicines and Healthcare products Regulatory Agency. Yasmin: risk of venous thromboembolism higher than levonorgestrel‐containing pills. December 2014. Available from:https://www.gov.uk/drug-safety-update/yasmin-risk-of-venous-thromboembolism-higher-than-levonorgestrel-containing-pills

2. Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database

3. Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause

4. Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia

5. Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexual health of women using combined oral contraceptive containing estetrol and drospirenone: A prospective observational study;Gynecology;2024-05-09